A phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration

被引:36
作者
Cao, Xuan [1 ,2 ]
Kaneko, Tomonori [1 ]
Li, Jenny S. [3 ]
Liu, An-Dong [2 ]
Voss, Courtney [1 ]
Li, Shawn S. C. [1 ,4 ]
机构
[1] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada
[2] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Med Genet, Tongji Med Coll, Wuhan 430030, Peoples R China
[3] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med, London, ON N6A 5C1, Canada
[4] Childrens Hlth Res Inst, London, ON N6C 2V5, Canada
关键词
TUMOR-SUPPRESSOR PTEN; BREAST-CANCER CELLS; MEMBRANE ASSOCIATION; PHOSPHATASE-ACTIVITY; PROTEIN DLC-1; C2; DOMAINS; SH2; DOMAIN; RAC; GROWTH; EGF;
D O I
10.1038/ncomms8721
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although cell migration plays a central role in development and disease, the underlying molecular mechanism is not fully understood. Here we report that a phosphorylation-mediated molecular switch comprising deleted in liver cancer 1 (DLC1), tensin-3 (TNS3), phosphatase and tensin homologue (PTEN) and phosphoinositide-3-kinase (PI3K) controls the spatiotemporal activation of the small GTPases, Rac1 and RhoA, thereby initiating directional cell migration induced by growth factors. On epidermal growth factor (EGF) or platelet-derived growth factor (PDGF) stimulation, TNS3 and PTEN are phosphorylated at specific Thr residues, which trigger the rearrangement of the TNS3-DLC1 and PTEN-PI3K complexes into the TNS3-PI3K and PTEN-DLC1 complexes. Subsequently, the TNS3-PI3K complex translocates to the leading edge of a migrating cell to promote Rac1 activation, whereas PTEN-DLC1 translocates to the posterior for localized RhoA activation. Our work identifies a core signalling mechanism by which an external motility stimulus is coupled to the spatiotemporal activation of Rac1 and RhoA to drive directional cell migration.
引用
收藏
页数:14
相关论文
共 64 条
[1]  
Barber Mark A, 2006, Bull Cancer, V93, pE44
[2]   Growth factors and cytokines in wound healing [J].
Barrientos, Stephan ;
Stojadinovic, Olivera ;
Golinko, Michael S. ;
Brem, Harold ;
Tomic-Canic, Marjana .
WOUND REPAIR AND REGENERATION, 2008, 16 (05) :585-601
[3]   The C2 domain of PKCδ is a phosphotyrosine binding domain [J].
Benes, CH ;
Wu, N ;
Elia, AEH ;
Dharia, T ;
Cantley, LC ;
Soltoff, SP .
CELL, 2005, 121 (02) :271-280
[4]   GEFs and GAPs: Critical elements in the control of small G proteins [J].
Bos, Johannes L. ;
Rehmann, Holger ;
Wittinghofer, Alfred .
CELL, 2007, 129 (05) :865-877
[5]   Rho and Rac take center stage [J].
Burridge, K ;
Wennerberg, K .
CELL, 2004, 116 (02) :167-179
[6]   New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway [J].
Cantley, LC ;
Neel, BG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4240-4245
[7]   Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation [J].
Cao, Xuan ;
Voss, Courtney ;
Zhao, Bing ;
Kaneko, Tomonori ;
Li, Shawn Shun-Cheng .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (05) :1455-1460
[8]   Membrane binding and subcellular targeting of C2 domains [J].
Cho, Wonhwa ;
Stahelin, Robert V. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2006, 1761 (08) :838-849
[9]   GDIs: central regulatory molecules in Rho GTPase activation [J].
DerMardirossian, C ;
Bokoch, GM .
TRENDS IN CELL BIOLOGY, 2005, 15 (07) :356-363
[10]   Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth [J].
Durkin, M. E. ;
Ullmannova, V. ;
Guan, M. ;
Popescu, N. C. .
ONCOGENE, 2007, 26 (31) :4580-4589